Tema ETFs
BCAX icon

Tema ETFs’s Bicara Therapeutics BCAX Stock Holding History

Tema ETFs’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$712K Buy
+38,259
New +$958K 0.03% 356

Other funds holding BCAX

RTM
Red Tree Management Redwood City, California $117M AUM 89.68% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Tema ETFs's BCAX Position: Q3 2026 in Review

Tema ETFs opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 38,259 shares worth $712K. The stake represents 0.03% of the portfolio and ranks #356 among its holdings.

8 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • Tema ETFs held 38,259 shares of Bicara Therapeutics worth $712K as of Q3 2026.
  • Bicara Therapeutics was a new Tema ETFs position in Q3 2026.
  • Bicara Therapeutics made up 0.03% of Tema ETFs's portfolio in Q3 2026, its #356 holding.
  • 8 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.